Neurol. praxi. 2017;18(5):301-304 | DOI: 10.36290/neu.2017.035

Scales and questionnaires used in myasthenia gravis

MUDr. Magda Horáková, MUDr. Stanislav Voháňka, CSc., MBA
Neurologická klinika FN a LF MU, Brno

Although a routine scoring of patients is not very popular, it can not be overlooked because it provides us a natural course of thedisease, efficacy of treatment and comparison of patients. There are specific attributes of myasthenia outcome measures due toa fluctuating nature of myasthenia. The aim of this article is a review of commonly used myasthenia scales with an emphasis onpractical implementation.

Keywords: scale, score, questionnaire, mysthenia gravis, measurement, MG Composite, QMG, MG-QOL15, MG-ADL.

Received: May 30, 2017; Accepted: July 26, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáková M, Voháňka S. Scales and questionnaires used in myasthenia gravis. Neurol. praxi. 2017;18(5):301-304. doi: 10.36290/neu.2017.035.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Barohn RJ, Herbelin L. The Quantitative Myasthenia Gravis (QMG) test the manual. Myasthenia Gravis Foundation of America; 2000.
    2. Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann. N. Y. Acad. Sci. 1998; 841: 769-772. Go to original source... Go to PubMed...
    3. Burns TM, Conaway M, Sanders DB, MG composite and MG-QOL15 Study Group. The MG composite: a valid and reliable outcome measure for myasthenia gravis. Neurology 2010; 74: 1434-1440. Go to original source... Go to PubMed...
    4. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve 2008; 38: 1553-1562. Go to original source... Go to PubMed...
    5. Burns TM, Grouse CK, Conaway MR, Sanders DB, MG composite and mg-qol15 study group. Construct and concurrent validation of the MG-QOL15 in the practice setting. Muscle Nerve 2010; 41: 219-226. Go to original source...
    6. Chmelíková M, Voháňka S, Bednařík J. Myasthenia gravis composite - validace české verze. Cesk Slov Neurol N 2016; 79: 585-590.
    7. Horakova M, Vohanka S, Bednarik J. Validation of myasthenia gravis quality of life questionnaire - Czech version of MG-QOL15. Cesk Slov Neurol N 2017; 80: 66-69.
    8. Mullins LL, Carpentier MY, Paul RH, Sanders DB. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 2008; 38: 947-956. Go to original source... Go to PubMed...
    9. Wolfe GI, Barohn RJ, Sanders DB, McDermott MP, Muscle Study Group. Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis. Muscle Nerve 2008; 38: 1429-1433. Go to original source... Go to PubMed...
    10. Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 1999; 52: 1487-1489. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.